Clinical trial
Combination Chemotherapy in Treating Patients With Previously Untreated, Newly…
NCT00004082 · Beth Israel Deaconess Medical Center, Other · Completed
Key facts
| NCT number | NCT00004082 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors |
| Official title | A Phase I Study of Docetaxel (Taxotere), Carboplatin, and Gemcitabine (DoCaGem) as First-Line Therapy for Patients With High-Risk Epithelial Tumors of Mullerian Origin |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, docetaxel, gemcitabine hydrochloride |
| Start date | Jul 1, 1999 |
| Primary completion | Sep 1, 2003 |
| Completion | Dec 1, 2010 |
| First posted | Apr 12, 2004 |
| Last update posted | Jun 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: